Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives (Q27012539)

language of work or name

1 reference

January 2014

1 reference

Basic and Clinical Pharmacology and Toxicology

published in

1 reference

volume

114

1 reference

issue

1

1 reference

page(s)

56-63

1 reference

The coxibs, selective inhibitors of cyclooxygenase-2.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Managing the adverse effects of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

NSAIDs and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Prostaglandins and leukotrienes: advances in eicosanoid biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Pharmacodynamic of cyclooxygenase inhibitors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Mechanistic aspects of COX-2 expression in colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Acetaminophen increases blood pressure in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Genotyping as a tool to predict adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

MicroRNA Involved in Inflammation: Control of Eicosanoid Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

COX-2 gene promoter haplotypes and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12117